Stock Earnings

Question 1

Lexicon Pharmaceuticals Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Lexicon Pharmaceuticals Inc'in toplam varlıkları $298 olup, net loss $-200'dir.

Question 2

LXRX'ün temel finansal oranları nelerdir?

Accepted Answer

Lexicon Pharmaceuticals Inc'in cari oranı 1.96, net kâr marjı -645.16, hisse başına satış $0.09'dir.

Question 3

Lexicon Pharmaceuticals Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Lexicon Pharmaceuticals Inc largest revenue segment is Pharmaceutical Products, at a revenue of 31,081,000 in the most earnings release.For geography, United States is the primary market for Lexicon Pharmaceuticals Inc, at a revenue of 31,081,000.

Question 4

Lexicon Pharmaceuticals Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Lexicon Pharmaceuticals Inc'in net loss $-200'dir.

Question 5

Lexicon Pharmaceuticals Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Lexicon Pharmaceuticals Inc'in yükümlülüğü 152'dir.

Question 6

Lexicon Pharmaceuticals Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Lexicon Pharmaceuticals Inc'in toplam tedavüldeki hisse sayısı 361.49'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	58	31	1	0	0	24
Revenue Growth (YoY)	1,832.99%	3,000%	--	--	-100%	-93%
Cost of Revenue	0	0	0	0	0	1
Gross Profit	57	30	1	0	0	22
Selling, General & Admin	92	143	113	48	32	47
Research & Development	83	84	58	52	55	153
Operating Expenses	176	227	172	100	87	200
Other Non Operating Income (Expenses)	10	12	7	1	0	2
Pretax Income	-120	-200	-177	-101	-87	-58
Income Tax Expense	--	--	--	--	0	0
Net Income	-120	-200	-177	-101	-87	-58
Net Income Growth	-41%	13%	75%	16%	50%	-145%
Shares Outstanding (Diluted)	363.57	320.03	221.13	165.7	145.7	110.8
Shares Change (YoY)	17%	45%	33%	14%	32%	-5%
EPS (Diluted)	-0.33	-0.62	-0.8	-0.62	-0.6	-0.53
EPS Growth	-49%	-22%	28.99%	3%	13%	-148%
Free Cash Flow	-102	-179	-162	-90	-88	-143
Free Cash Flow Per Share	-0.28	-0.55	-0.73	-0.54	-0.6	-1.29
Gross Margin	98.27%	96.77%	100%	0%	0%	91.66%
Operating Margin	-203.44%	-635.48%	-17,100%	0%	0%	-741.66%
Profit Margin	-206.89%	-645.16%	-17,700%	0%	0%	-241.66%
Free Cash Flow Margin	-175.86%	-577.41%	-16,200%	0%	0%	-595.83%
EBITDA	-118	-197	-171	-100	-87	-176
EBITDA Margin	-203.44%	-635.48%	-17,100%	0%	0%	-733.33%
D&A For EBITDA	0	0	0	0	0	2
EBIT	-118	-197	-171	-100	-87	-178
EBIT Margin	-203.44%	-635.48%	-17,100%	0%	0%	-741.66%
Effective Tax Rate	--	--	--	--	0%	0%

Lexicon Pharmaceuticals Inc (LXRX) Price

LXRX Stock Price Chart

LXRX Income

Follow-Up Questions